Result of General Meeting & TVR

RNS Number : 9536W

Directa Plus PLC

29 December 2021

 

29 December 2021

Directa Plus plc

Result of General Meeting

Total Voting Rights

Directa Plus (AIM: DCTA) (the "Company"), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, is pleased to announce that both resolutions put to Shareholders at the General Meeting of the Company held earlier today, in connection with the Fundraising announced on 9 December 2021, were duly passed, each with 99.99 per cent. of votes in favour.

Application has been made to the London Stock Exchange for a total of 4,666,667 New Ordinary Shares to be admitted to trading on AIM. It is expected that Admission will become effective and that trading will commence at 8.00 a.m. on 30 December 2021. The total issued share capital of the Company, as increased by the New Ordinary Shares, immediately following Admission will be 66,032,126 Ordinary Shares. The above figure of 66,032,126 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to, their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Capitalised terms not otherwise defined in the text of this Announcement have the meanings given in the Company's announcement regarding the proposed Fundraising released at 12.30p.m. on 9 December 2021.

For further information please visit http://www.directa-plus.com/ or contact:

Directa Plus plc	[phone]
Giulio Cesareo, CEO
Giorgio Bonfanti, CFO
Cenkos Securities plc (Nominated Adviser and Joint Broker)	[phone]
Neil McDonald
Adam Rae
Singer Capital Markets Securities Limited (Joint Broker)	[phone]
Rick Thompson
Phil Davies
Tavistock (Financial PR and IR)	[phone]
Simon Hudson
Heather Armstrong

Notes to Editors

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products.

Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+) have multiple applications due to its properties. These G+ products can be categorised into various families, with different products being suitable for specific practical applications.

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. Directa Plus holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.

-ends-

 

END

 

 

MSCGZMZZMLRGMZM